- Home
- TARS vs BLKB Comparison
TARS vs BLKB Comparison
Compare TARS & BLKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | BLKB |
|---|---|---|
| Founded | 2016 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.7B |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | TARS | BLKB |
|---|---|---|
| Price | $81.84 | $64.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | ★ $76.56 | $70.50 |
| AVG Volume (30 Days) | ★ 514.1K | 341.2K |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $366,100,000.00 | ★ $1,136,093,000.00 |
| Revenue This Year | $147.24 | N/A |
| Revenue Next Year | $53.11 | $4.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 182.44 | N/A |
| 52 Week Low | $38.51 | $54.56 |
| 52 Week High | $85.25 | $81.39 |
Technical Indicators
Market Signals| Indicator | TARS | BLKB |
|---|---|---|
| Relative Strength Index (RSI) | 58.83 | 60.19 |
| Support Level | $77.14 | $62.57 |
| Resistance Level | $84.07 | $64.84 |
| Average True Range (ATR) | 2.91 | 1.72 |
| MACD | -0.19 | 0.21 |
| Stochastic Oscillator | 58.84 | 84.38 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.